Samer Thanavaro
Cardiovascular Disease · Saint Louis, MONPI 1619960606
Payments from drug & device makers
Across 239 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Johnson & Johnson$480
- Merck$310
- Sanofi-aventis U.S. LLC$215
- Amarin Pharma, Inc.$213
- Amgen$190
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,696100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 75 | $1,024 |
| Johnson & Johnson | 33 | $480 |
| Merck | 19 | $310 |
| Sanofi-aventis U.S. LLC | 12 | $215 |
| Amarin Pharma, Inc. | 16 | $213 |
| Amgen | 11 | $190 |
| E.r. Squibb & Sons, L.L.C. | 11 | $182 |
| Pfizer | 11 | $181 |
| AstraZeneca | 12 | $167 |
| Boehringer Ingelheim | 8 | $155 |
| Abbott | 2 | $152 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $123 |
| Bayer | 4 | $61 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Kestra Medical Technology Services, Inc. | 2 | $34 |
| Lexicon Pharmaceuticals, Inc. | 2 | $29 |
| Cvrx, Inc. | 1 | $26 |
| Medtronic | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $19 |
| Bardy Diagnostics, Inc. | 1 | $19 |
| Impulse Dynamics (USA) Inc. | 1 | $16 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$136
How this compares
$3,708 in reported general payments places this provider in the 55th percentile of 391 cardiovascular disease providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 299 | $269,248 |
| XareltoRivaroxaban | 105 | $103,372 |
| EntrestoSacubitril/Valsartan | 82 | $81,777 |
| JardianceEmpagliflozin | 19 | $13,796 |
| FarxigaDapagliflozin Propanediol | 22 | $12,818 |
| Ranolazine ErRanolazine | 37 | $5,333 |
| Metoprolol Succinate | 237 | $3,752 |
| Midodrine Hcl | 25 | $3,453 |
| Atorvastatin Calcium | 141 | $1,664 |
| Amiodarone Hcl | 97 | $1,543 |
| Flecainide Acetate | 25 | $1,495 |
| Furosemide | 212 | $1,277 |
| Carvedilol | 120 | $1,218 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 55 | $1,130 |
| Losartan Potassium | 109 | $1,049 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $181 | $269,248299 claims |
| Johnson & JohnsonXarelto | $480 | $103,372105 claims |
| NovartisEntresto | $1,024 | $81,77782 claims |
| Boehringer IngelheimJardiance | $155 | $13,79619 claims |
| AstraZenecaFarxiga | $167 | $12,81822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 391 cardiovascular disease providers in Missouri.
Other cardiovascular disease in Saint Louis
- Mohammad TahirSaint Louis$2.7M
- Joshua MitchellSaint Louis$1.4M
- Nathan StitzielSaint Louis$1.2M
- Daniel KellySaint Louis$1.1M
- Georges ChahoudSaint Louis$967K
- Jiafu OuSaint Louis$853K
- William BowenSaint Louis$726K
- Mustafa HusainiSaint Louis$465K
- Denise JanosikSaint Louis$295K
- Farhan KatchiSaint Louis$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.